Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
Plos One
|
April 13, 2018
Estimated prevalence of undiagnosed atrial fibrillation in the United States
Mintu P Turakhia, Jason Shafrin, Katalin Bognar, et al.
Cancer Management and Research
|
December 15, 2017
The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma
Jason Shafrin, Jeffrey Sullivan, Jacquelyn W Chou, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 27, 2016
Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia
Joanna P MacEwan, Felicia M Forma, Jason Shafrin, et al.
Current Medical Research and Opinion
|
August 27, 2025
Caregiver risk preferences for delaying loss of ambulation in Duchenne muscular dystrophy in the United States
Jason Shafrin, Nadine Zawadzki, Moises Marin, et al.
Health Affairs Scholar
|
March 24, 2025
Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers
Sean R Tunis, Jason Shafrin, Kyi-Sin Than, et al.
Health Policy (Amsterdam, Netherlands)
|
May 8, 2018
An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?
Jason Shafrin, Michelle Skornicki, Michelle Brauer, et al.
BMJ Open
|
September 19, 2020
Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis
Howard Thom, Jeroen Jansen, Jason Shafrin, et al.
Journal of Market Access & Health Policy
|
February 23, 2026
Pulmonary Arterial Hypertension and Cancer: Unveiling Parallels in Epidemiology, Clinical Pathways, and Therapeutic Strategies
Karim Ei-Kersh, Nadine Zawadzki, Catelyn Coyle, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2024
Quantifying the Value of Reduced Health Disparities: Low-Dose Computed Tomography Lung Cancer Screening of High-Risk Individuals Within the United States
Jason Shafrin, Jaehong Kim, Moises Marin, et al.
Journal of Medical Economics
|
July 19, 2021
Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlist
Syvart Dennen, Oliver Díaz Espinosa, Kelly Birch, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
Plos One
|
April 13, 2018
Estimated prevalence of undiagnosed atrial fibrillation in the United States
Mintu P Turakhia, Jason Shafrin, Katalin Bognar, et al.
Cancer Management and Research
|
December 15, 2017
The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma
Jason Shafrin, Jeffrey Sullivan, Jacquelyn W Chou, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 27, 2016
Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia
Joanna P MacEwan, Felicia M Forma, Jason Shafrin, et al.
Current Medical Research and Opinion
|
August 27, 2025
Caregiver risk preferences for delaying loss of ambulation in Duchenne muscular dystrophy in the United States
Jason Shafrin, Nadine Zawadzki, Moises Marin, et al.
Health Affairs Scholar
|
March 24, 2025
Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers
Sean R Tunis, Jason Shafrin, Kyi-Sin Than, et al.
Health Policy (Amsterdam, Netherlands)
|
May 8, 2018
An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?
Jason Shafrin, Michelle Skornicki, Michelle Brauer, et al.
BMJ Open
|
September 19, 2020
Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis
Howard Thom, Jeroen Jansen, Jason Shafrin, et al.
Journal of Market Access & Health Policy
|
February 23, 2026
Pulmonary Arterial Hypertension and Cancer: Unveiling Parallels in Epidemiology, Clinical Pathways, and Therapeutic Strategies
Karim Ei-Kersh, Nadine Zawadzki, Catelyn Coyle, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2024
Quantifying the Value of Reduced Health Disparities: Low-Dose Computed Tomography Lung Cancer Screening of High-Risk Individuals Within the United States
Jason Shafrin, Jaehong Kim, Moises Marin, et al.
Journal of Medical Economics
|
July 19, 2021
Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlist
Syvart Dennen, Oliver Díaz Espinosa, Kelly Birch, et al.
Page
of 9